The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model

Laboratory Investigation

Volumn 93, Issue 7, 2013, Pages 825-833

  Guo, Yansu ^a,b,c   Zhang, Yuesheng ^d   Wen, Di ^a   Duan, Weisong ^a,b,c   An, Ting ^a   Shi, Pengxiao ^a   Wang, Jingjing ^a   Li, Zhongyao ^a,b,c   Chen, Xiaoyu ^a   Li, Chunyan ^a,b,c  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Hebei Neurology   (China)

^c Institute of Cardiocerebrovascular Disease   (China)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

amyotrophic lateral sclerosis (ALS); cytoprotective phase 2 enzyme; NF E2 related factor 2 (Nrf2); oxidative stress; SOD1

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR NRF2;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE MUTATION; GENE SILENCING; LUMBAR SPINAL CORD; MALE; MOTONEURON; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 84879676316     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.73     Document Type: Article

References (40)

1. Rowland LP. Amyotrophic lateral sclerosis. Curr Opin Neurol 1994;7:310-315. (Pubitemid 24243734)
2. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62. (Pubitemid 23087289)
3. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994;264:1772-1775. (Pubitemid 24227760)
4. Ferrante RJ, Browne SE, Shinobu LA, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997e;69:2064-2074. (Pubitemid 27452754)
5. Drechsel DA, Estevez AG, Barbeito L, et al. Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS. Neurotox Res 2012;22:251-264.
6. Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 2010;48:629-641.
7. Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997e;236:313-322. (Pubitemid 27373291)
8. Gong P, Stewart D, Hu B, et al. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2. Antioxid Redox Signal 2002e;4:249-257. (Pubitemid 34517176)
9. Kim HJ, Zheng M, Kim SK, et al. CO/HO-1 induces NQO-1 expression via Nrf2 activation. Immune Netw 2011;11:376-382.
10. Chan K, Han XD, Kan YW. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc Natl Acad Sci USA 2001e;98:4611-4616. (Pubitemid 32295024)
11. Alam J, Stewart D, Touchard C, et al. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 1999e;274:26071-26078.
12. Neymotin A, Calingasan NY, Wille E, et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 2011;51:88-96.
13. Guo Y, Zhang K, Wang Q, et al. Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Brain Res 2011;1374:110-115.
14. Mimoto T, Miyazaki K, Morimoto N, et al. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice. Brain Res 2012;1446:109-118.
15. Guo Y, Duan W, Li Z, et al. Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice. FEBS Lett 2010;584: 1615-1622.
16. Weydt P, Hong SY, Kliot M, et al. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003e;14:1051-1054. (Pubitemid 36829789)
17. Duan W, Zhang R, Guo Y, et al. Nrf2 activity is lost in the spinal cord and its astrocytes of aged mice. In Vitro Cell Dev Biol Anim 2009;45:388-397.
18. Li CY, Liu XY, Bu H, et al. Prevention of glutamate excitotoxicity in motor neurons by 5,6-dihydrocyclopenta-1,2-dithiole-3-thione: implication to the development of neuroprotective drugs. Cell Mol Life Sci 2007e;64:1861-1869. (Pubitemid 47093017)
19. Barbeito LH, Pehar M, Cassina P, et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 2004e;47:263-274. (Pubitemid 39574324)
20. Johnson JA, Johnson DA, Kraft AD, et al. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci 2008e;1147:61-69.
21. Scapagnini G, Vasto S, Abraham NG, et al. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 2011;44192-201.
22. Vargas MR, Johnson DA, Johnson JA. Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model. Neurobiol Dis 2011;43:543-551.
23. Dickinson DA, Forman HJ. Glutathione in defense and signaling: lessons from a small thiol. Ann N Y Acad Sci 2002e;973:488-504. (Pubitemid 36131049)
24. Levine JB, Kong J, Nadler M, et al. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 1999;28:215-224.
25. Schipper HM, Song W, Zukor H, et al. Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 2009e;110:469-485.
26. Schipper HM, Cisse S, Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 1995e;37:758-768.
27. Raina AK, Templeton DJ, Deak JC, et al. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox Rep 1999e;4:23-27. (Pubitemid 29296777)
28. Stahnke T, Stadelmann C, Netzler A, et al. Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders. J Mol Neurosci 2007e;32:25-37. (Pubitemid 47450554)
29. Yang C, Zhang X, Fan H, et al. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009e;1282:133-141.
30. Wruck CJ, Fragoulis A, Gurzynski A, et al. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis 2011;70:844-850.
31. Hong Y, Yan W, Chen S, et al. The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice. Acta Pharmacol Sin 2010;31:1421-1430.
32. Son M, Puttaparthi K, Kawamata H, et al. Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc Natl Acad Sci USA 2007e; 104:6072-6077. (Pubitemid 47175660)
33. Zhang Y, Tang L. Discovery and development of sulforaphane as a cancer chemopreventive phytochemical. Acta Pharmacol Sin 2007e;28:1343-1354. (Pubitemid 47366676)
34. Piao MS, Park JJ, Choi JY, et al. Nrf2-dependent and Nrf2-independent induction of phase 2 detoxifying and antioxidant enzymes during keratinocyte differentiation. Arch Dermatol Res 2012;304:387-395.
35. Wright MM, Kim J, Hock TD, et al. Human haem oxygenase-1 induction by nitro-linoleic acid is mediated by cAMP, AP-1 and E-box response element interactions. Biochem J 2009e;422:353-361.
36. Zhao R, Hou Y, Xue P, et al. Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes. Environ Health Perspect 2011;119:56-62.
37. Braun S, Hanselmann C, Gassmann MG, et al. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol Cell Biol 2002e;22:5492-5505. (Pubitemid 34755759)
38. Nagai M, Re DB, Nagata T, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007e;10:615-622. (Pubitemid 46652435)
39. Vargas MR, Johnson DA, Sirkis DW, et al. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 2008e;28: 13574-13581.
40. Kraft AD, Johnson DA, Johnson JA. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tertbutylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 2004e;24:1101-1112. (Pubitemid 38177017)